# Ex Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator for Intracerebral Hemorrhage

> **NCT07411079** · — · NOT_YET_RECRUITING · sponsor: **University Hospital, Lille** · enrollment: 1126 (estimated)

## Conditions studied

- Intracerebral Hemorrhage
- Hemorrhagic Risk Conditions
- Bleeding Disorders

## Interventions

- **OTHER:** Ex vivo exposure to modified rtPA

## Key facts

- **NCT ID:** NCT07411079
- **Lead sponsor:** University Hospital, Lille
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2026-02
- **Final completion:** 2026-02
- **Target enrollment:** 1126 (ESTIMATED)
- **Last updated:** 2026-02-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07411079

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07411079, "Ex Vivo Reproduction of Minimally Invasive Surgery With Hematoma Lysis Using Modified Tissue Plasminogen Activator for Intracerebral Hemorrhage". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07411079. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*